Citation Impact
Citing Papers
Pathophysiology of Migraine: A Disorder of Sensory Processing
2017 Standout
Normal gut microbiota modulates brain development and behavior
2011 Standout
The clinical symptoms of Parkinson's disease
2016 Standout
Deep Brain Stimulation for Treatment-Resistant Depression
2005 Standout
Current Status of Augmentation and Combination Treatments for Major Depressive Disorder: A Literature Review and a Proposal for a Novel Approach to Improve Practice
2006
Research issues in the study of difficult-to-treat depression
2003
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders, Part 1: Acute and Continuation Treatment of Major Depressive Disorder
2002
Medication Augmentation after the Failure of SSRIs for Depression
2006 Standout
Acute and Longer-Term Outcomes in Depressed Outpatients Requiring One or Several Treatment Steps: A STAR*D Report
2006 Standout
The Medical Management of Depression
2005
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Unipolar Depressive Disorders in Primary Care
2007
Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application
2006
Cognitive Function Across Manic or Hypomanic, Depressed, and Euthymic States in Bipolar Disorder
2004 Standout
Enhancing outcomes in the management of treatment resistant depression: a focus on atypical antipsychotics
2003
Depression
2018 Standout
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
2006 Standout
Augmentation of Antidepressants with Atypical Antipsychotics: A Review of the Current Literature
2008
Major depressive disorder
2016 Standout
Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis
2017
Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders
2015
A questionnaire-based (UM-PDHQ) study of hallucinations in Parkinson's disease
2008
The efficacy and safety of risperidone in the treatment of psychosis of Alzheimer's disease and mixed dementia: a meta‐analysis of 4 placebo‐controlled clinical trials
2007
Targeting the KEAP1-NRF2 System to Prevent Kidney Disease Progression
2017 Standout
The locus coeruleus–noradrenergic system: modulation of behavioral state and state-dependent cognitive processes
2003 Standout
Parkinson disease
2017 Standout
The Worldwide Prevalence of ADHD: A Systematic Review and Metaregression Analysis
2007 Standout
Differential effects of adjunctive methylphenidate and citalopram on extracellular levels of serotonin, noradrenaline and dopamine in the rat brain
2007
5-HT2 receptors modulate excitatory neurotransmission to cardiac vagal neurons within the nucleus ambiguus evoked during and after hypoxia
2009 StandoutNobel
A Double-Blind Randomized Pilot Study Comparing Quetiapine and Divalproex for Adolescent Mania
2006
Lithium Treatment of Acute Mania in Adolescents: A Placebo-Controlled Discontinuation Study
2004
Why Olanzapine Beats Risperidone, Risperidone Beats Quetiapine, and Quetiapine Beats Olanzapine: An Exploratory Analysis of Head-to-Head Comparison Studies of Second-Generation Antipsychotics
2006
A comprehensive map of molecular drug targets
2016 Standout
Risk of Death With Atypical Antipsychotic Drug Treatment for Dementia
2005
Descending control of pain
2002 Standout
Neurocognitive performance and negative symptoms: Are they equal in explaining disability in schizophrenia outpatients?
2006
The 2009 Schizophrenia PORT Psychopharmacological Treatment Recommendations and Summary Statements
2009
Antipsychotic agents in the treatment of bipolar mania
2009
Chronic olanzapine or fluoxetine administration increases cell proliferation in hippocampus and prefrontal cortex of adult rat
2004
Pharmacology of antidepressants
2001
Child and adolescent mental health worldwide: evidence for action
2011 Standout
Epidemiology of psychosis in Parkinson's disease
2009
Aripiprazole for the Treatment of Psychosis in Patients With Alzheimer's Disease
2005
Alzheimer's disease
2011 Standout
Physiology and Neurobiology of Stress and Adaptation: Central Role of the Brain
2007 Standout
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
In Vivo Modulation of the Activity of Pyramidal Neurons in the Rat Medial Prefrontal Cortex by 5-HT2A Receptors: Relationship to Thalamocortical Afferents
2003
Cognitive Deficits and Psychosis in Parkinson???s Disease
2006
Parkinson's disease: clinical features and diagnosis
2008 Standout
Network pharmacology: the next paradigm in drug discovery
2008 Standout
Impulsivity, Compulsivity, and Top-Down Cognitive Control
2011 Standout
World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, Part 1: Update 2012 on the acute treatment of schizophrenia and the management of treatment resistance
2012
Atypical Antipsychotic Augmentation for Treatment-Resistant Depression: A Systematic Review and Network Meta-Analysis
2015
Psychedelics
2016 Standout
The 5-hydroxytryptamine1B/1D/1F receptor agonists eletriptan and naratriptan inhibit trigeminovascular input to the nucleus tractus solitarius in the cat
2003
Versión española de una escala de evaluación de la manía: validez y fiabilidad de la Escala de Young
2002
A Double-Blind, Randomized, Placebo-Controlled Study of Quetiapine as Adjunctive Treatment for Adolescent Mania
2002
What Happened to Lithium? Antidepressant Augmentation in Clinical Settings
2006
Packages of Care for Attention-Deficit Hyperactivity Disorder in Low- and Middle-Income Countries
2010
Effectiveness of psychotropic medications in the maintenance phase of bipolar disorder: a meta-analysis of randomized controlled trials
2011
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
2013 Standout
Efficacy and Adverse Effects of Atypical Antipsychotics for Dementia: Meta-analysis of Randomized, Placebo-Controlled Trials
2006
Similar Effects of the Selective Noradrenaline Reuptake Inhibitor Atomoxetine on Three Distinct Forms of Impulsivity in the Rat
2007
Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial
2011
The relationship between neurocognition and social cognition with functional outcomes in schizophrenia: A meta-analysis
2010 Standout
Nonpharmacological Treatment of Agitation: A Controlled Trial of Systematic Individualized Intervention
2007
Parkinson's disease
2015 Standout
The effects of noradrenergic activation of the nucleus tractus solitarius on memory and in potentiating norepinephrine release in the amygdala.
2000
The Physiology, Signaling, and Pharmacology of Dopamine Receptors
2011 Standout
Meta-Analysis of the Effectiveness of Atypical Antipsychotics for the Treatment of Behavioural Problems in Persons with Dementia
2007
The Dopamine Hypothesis of Schizophrenia: Version III--The Final Common Pathway
2009 Standout
A β-arrestin 2 Signaling Complex Mediates Lithium Action on Behavior
2008 StandoutNobel
Treatment of Cognitive, Psychiatric, and Affective Disorders Associated with Parkinson's Disease
2013
Pimavanserin for the treatment of Parkinson's disease psychosis
2013
Power failure: why small sample size undermines the reliability of neuroscience
2013 Standout
Interchangeable discharge patterns of neurons in caudal nucleus tractus solitarii in rat slices: role of GABA and NMDA
1997
Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals
2003 Standout
Targeting norepinephrine in mild cognitive impairment and Alzheimer's disease
2013
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis
2009 Standout
Pharmacological Treatment of Neuropsychiatric Symptoms of Dementia
2005
Major Depressive Disorder
2008 Standout
Mental health of young people: a global public-health challenge
2007 Standout
Noradrenergic Receptor Blockade of the NTS Attenuates the Mnemonic Effects of Epinephrine in an Appetitive Light–Dark Discrimination Learning Task
2000
Non-motor features of Parkinson disease
2017 Standout
Comparing Tolerability of Olanzapine in Schizophrenia and Affective Disorders
2012
Utility of Atypical Antipsychotics in the Treatment of Resistant Unipolar Depression
2009
Pathophysiology and Treatment of Psychosis in Parkinson’s Disease
2008
Algorithms and Collaborative-care Systems for Depression: Are They Effective and Why?
2006
New approaches to understanding hallucinations in Parkinson’s disease: phenomenology and possible origins
2007
AGA technical review on irritable bowel syndrome
2002 Standout
Adrenergic activation of the nucleus tractus solitarius potentiates amygdala norepinephrine release and enhances retention performance in emotionally arousing and spatial memory tasks
2000
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis
2013 Standout
Updating and Confirming an Industry-Sponsored Pharmacoeconomic Model: Comparing Two Antipsychotics in the Treatment of Schizophrenia
2011
Assessment and management of behavioral and psychological symptoms of dementia
2015 Standout
Mortality Risk in Patients With Dementia Treated With Antipsychotics Versus Other Psychiatric Medications
2007
Serotonin2 Receptors in the Nucleus Tractus Solitarius: Characterization and Role in the Baroreceptor Reflex Arc
2003
Industry sponsorship and research outcome
2012 Standout
Oxidant Mechanisms in Renal Injury and Disease
2016
Diagnosis and Treatment of Parkinson Disease
2020 Standout
Pharmacological interventions for somatoform disorders in adults
2014 Standout
The Movement Disorder Society Evidence‐Based Medicine Review Update: Treatments for the non‐motor symptoms of Parkinson's disease
2011
Practice Parameter for the Assessment and Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder
2007 Standout
Risperidone versus other atypical antipsychotics for schizophrenia
2011
What Happened to Lithium? Antidepressant Augmentation in Clinical Settings
2006
Non-motor Symptoms of Parkinson's Disease
2007
Neuroleptic drugs in dementia: benefits and harm
2006
Pathophysiology of Sleep Apnea
2010 Standout
THE AMYGDALA MODULATES THE CONSOLIDATION OF MEMORIES OF EMOTIONALLY AROUSING EXPERIENCES
2004 Standout
The cholinergic system in the pathophysiology and treatment of Alzheimer’s disease
2018 Standout
Differences in reporting serious adverse events in industry sponsored clinical trial registries and journal articles on antidepressant and antipsychotic drugs: a cross-sectional study
2014
The effects of noradrenergic activation of the nucleus tractus solitarius on memory and in potentiating norepinephrine release in the amygdala.
2000
Sodium/Calcium Exchange: Its Physiological Implications
1999 Standout
Pontomedullary distribution of 5-HT2A receptor-like protein in the rat
2000
Interventions for preventing falls in older people living in the community
2012 Standout
Industry sponsorship and research outcome
2017 Standout
An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability
2002
Works of Peter D. Feldman being referenced
Comparison of Olanzapine and Risperidone in the Treatment of Psychosis and Associated Behavioral Disturbances in Patients With Dementia
2005
Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease
2004
Efficacy of Olanzapine in Combination With Valproate or Lithium in the Treatment of Mania in Patients Partially Nonresponsive to Valproate or Lithium Monotherapy
2002
Drug-Induced Psychosis in Parkinson Disease
2005
Relapse prevention in bipolar I disorder: 18-month comparison of olanzapine plus mood stabiliser v. mood stabiliser alone
2004
Effects of Long-Term Atomoxetine Treatment for Young Children With Attention-Deficit/Hyperactivity Disorder
2006
Olanzapine in the treatment of dopamimetic-induced psychosis in patients with Parkinson’s disease
2002
A Prospective Open-Label Treatment Trial of Olanzapine Monotherapy in Children and Adolescents with Bipolar Disorder
2001
Effect of Two Different Methods of Initiating Atomoxetine on the Adverse Event Profile of Atomoxetine
2007
Electrophysiological effects of serotonin in the solitary tract nucleus of the rat
1994
Adrenergic responses of baroreceptive cells in the nucleus tractus solitarii of the rat: a microiontophoretic study
1987
Atomoxetine Augmentation of Cholinesterase Inhibitor Therapy in Patients With Alzheimer Disease: 6-Month, Randomized, Double-Blind, Placebo-Controlled, Parallel-Trial Study
2009
Long-term efficacy of olanzapine in the control of psychotic and behavioral symptoms in nursing home patients with Alzheimer's dementia
2001
Olanzapine in the acute treatment of bipolar I disorder with a history of rapid cycling
2002
A Novel Augmentation Strategy for Treating Resistant Major Depression
2001
Olanzapine versus clozapine in treatment-resistant or treatment-intolerant schizophrenia
2003
The Effects of Olanzapine in Reducing the Emergence of Psychosis Among Nursing Home Patients With Alzheimer's Disease
2001
α2-Adrenergic modulation of synaptic excitability in the rat nucleus tractus solitarius
1989
Comparison of Risperidone and Olanzapine in the Control of Negative Symptoms of Chronic Schizophrenia and Related Psychotic Disorders in Patients Aged 50 to 65 Years
2003
Effects of serotonin-1 and serotonin-2 receptor agonists on neuronal activity in the nucleus tractus solitarius
1995
Onset of action of antipsychotics in the treatment of mania
2000